Clin J Oncol Nurs. 2004 Apr;8(2):212-4.

Translational research in cancer complementary and alternative medicine: the National Cancer Institute's Best Case Series Program.

Source

Office of Cancer Complementary and Alternative Medicine, National Cancer Institute in Bethesda, MD, USA. leeco@mail.nih.gov

Abstract

Public interest in CAM for cancer care likely will influence the need for continued scientific evaluation. The NCI BCS program evaluates case studies involving novel alternative therapies for cancer treatment. Through the NCI BCS program, meaningful data are generated that may lead to NCI-supported research projects, including prospective studies, clinical trials, and advances in scientific knowledge. Individuals interested in obtaining a submission packet for the NCI BCS program may access the official OCCAM Web site at http://www3.cancer.gov/occam/ or call 301-435-7980.

PMID:: 15108425; [PubMed - indexed for MEDLINE]

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Related citations

Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience. [J Clin Oncol. 2005]
Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience.
Buchanan DR, White JD, O'Mara AM, Kelaghan JW, Smith WB, Minasian LM. J Clin Oncol. 2005 Sep 20; 23(27):6682-9.
Review Use of the best case series to evaluate complementary and alternative therapies for cancer: a systematic review. [Semin Oncol. 2002]
Review Use of the best case series to evaluate complementary and alternative therapies for cancer: a systematic review.
Nahin RL. Semin Oncol. 2002 Dec; 29(6):552-62.
Review The National Cancer Institute's perspective and agenda for promoting awareness and research on alternative therapies for cancer. [J Altern Complement Med. 2002]
Review The National Cancer Institute's perspective and agenda for promoting awareness and research on alternative therapies for cancer.
White JD. J Altern Complement Med. 2002 Oct; 8(5):545-50.
National Cancer Institute's OCCAM partners with NCCAM to expand research on unconventional cancer treatments. [Altern Ther Health Med. 1999]
National Cancer Institute's OCCAM partners with NCCAM to expand research on unconventional cancer treatments.
Muscat M. Altern Ther Health Med. 1999 Jul; 5(4):26-30.
Use of complementary medicine by adult patients participating in cancer clinical trials. [Oncol Nurs Forum. 2000]
Use of complementary medicine by adult patients participating in cancer clinical trials.
Sparber A, Bauer L, Curt G, Eisenberg D, Levin T, Parks S, Steinberg SM, Wootton J. Oncol Nurs Forum. 2000 May; 27(4):623-30.

See reviews... See all...

Cited by 1 PubMed Central article

Understanding unexpected courses of multiple sclerosis among patients using complementary and alternative medicine: A travel from recipient to explorer. [Int J Qual Stud Health Well-being. 2010]
Understanding unexpected courses of multiple sclerosis among patients using complementary and alternative medicine: A travel from recipient to explorer.
Salamonsen A, Launsø L, Kruse TE, Eriksen SH. Int J Qual Stud Health Well-being. 2010 Jul 2; 5. Epub 2010 Jul 2.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Translational research in cancer complementary and alternative medicine: the Nat...
Translational research in cancer complementary and alternative medicine: the National Cancer Institute's Best Case Series Program.
Clin J Oncol Nurs. 2004 Apr ;8(2):212-4.

PubMed
Cytolytic CD8+ T cells directed against a cryptic epitope derived from a retrovi...
Cytolytic CD8+ T cells directed against a cryptic epitope derived from a retroviral alternative reading frame confer disease protection.
J Immunol. 2006 Feb 15 ;176(4):2470-5.

PubMed
Periostin mediates vascular smooth muscle cell migration through the integrins a...
Periostin mediates vascular smooth muscle cell migration through the integrins alphavbeta3 and alphavbeta5 and focal adhesion kinase (FAK) pathway.
Atherosclerosis. 2010 Feb ;208(2):358-65. Epub 2009 Jul 30 .

PubMed
Assessing outcomes in psychiatric practice: guidelines, challenges, and solution...
Assessing outcomes in psychiatric practice: guidelines, challenges, and solutions.
Harv Rev Psychiatry. 2000 Dec ;8(6):323-7.

PubMed
PC-SPES--a lesson for future dietary supplement research.
PC-SPES--a lesson for future dietary supplement research.
J Natl Cancer Inst. 2002 Sep 4 ;94(17):1261-3.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Translational research in cancer complementary and alternative medicine: the National Cancer Institute's Best Case Series Program.

Source

Abstract

MeSH Terms

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Related citations

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information